Osimertinib regressed an EGFR-mutant lung-adenocarcinoma bone-metastasis mouse model and increased long-term survival
Translational oncology, 2020-10, Vol.13 (10), p.100826-100826, Article 100826 [Peer Reviewed Journal]2020 The Authors ;Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved. ;2020 The Authors 2020 ;ISSN: 1936-5233 ;EISSN: 1936-5233 ;DOI: 10.1016/j.tranon.2020.100826 ;PMID: 32659740
Full text available